CIM
VRTX icon

CenturyLink Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

CenturyLink Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-6,341
Closed -$504K – 254
2016
Q1 		$504K Buy
+6,341
New +$574K 0.18% 160

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

CenturyLink Investment Management's VRTX Position: Q2 2016 in Review

CenturyLink Investment Management sold out of Vertex Pharmaceuticals (VRTX) in Q2 2016, closing a stake of 6,341 shares — an estimated $504K sold.

CenturyLink Investment Management first reported a position in VRTX in Q1 2016 and held it in 1 quarter. The position peaked at $504K in Q1 2016. 483 funds tracked by Wall St. Rank hold VRTX as of Q2 2016.

  • CenturyLink Investment Management reported no remaining Vertex Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • CenturyLink Investment Management sold 6,341 Vertex Pharmaceuticals shares in Q2 2016, an estimated $504K.
  • CenturyLink Investment Management first reported a position in Vertex Pharmaceuticals in Q1 2016 and held it in 1 quarter.
  • CenturyLink Investment Management's Vertex Pharmaceuticals position peaked at $504K in Q1 2016.
  • 483 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2016.

Based on CenturyLink Investment Management's 13F filing for Q2 2016, filed 7 Jul 2016.